SOM BIOTECH
 

SOM BIOTECH, The drug repositioning company

SOM  Biotech (SOM)  is a company established at the Barcelona Science Park with the mission to discover and develop new indications of already known drugs (repositioning) through a profitable private company committed to its shareholders, employees and society. Repositioned drug access implies discovering, pre-clinical validation, patenting and licensing already known drugs for their commercial use in unknown medical uses.  Our propietary virtual screening  platform is based on an in-silico computerized approach and the drug development is driven by a dedicated team of experts and strategy advisors.

 

Hot News

SOM presents its business model at the 6th Healthcare Investment Forum

Feb 16 th, 2012

The COMB, ESADE BAN, Barcelona Activa and Biocat are together organising the 6th Healthcare Investment Forum, Barcelona 2012. The Forum is the ideal meeting point for companies with biotechnology projects, medical teams, health services and information technologies related to the health industry, and investors interested in this sector.

 
SOM at BioBusiness 2012 in London

Jan 27th, 2012

SOM Biotech will attend BioBusiness 2012 that will take place from 31 January to 2 February 2012 in London. BioBusiness is the leading high-level BioPharma strategy and bio-partnering conference.


 
SOM invited in the Biotech Showcase and J.P. Morgan Healthcare Conference

Jan 5th, 2012

SOM Biotech will present the company to private investors during the Biotech Showcase™ and J.P. Morgan Healthcare Conference that will take place from 9th to 12th January 2012 in San Francisco, CA.

 

BIOINCUBADORA

innova31

logo_biocat_rgb

Catalonia BIO

asebio

Genoma España

NEWS